Cargando…
Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure
Introduction: Over time and despite optimal medical management of patients with pulmonary hypertension (PH), the right ventricle (RV) function deteriorates from an adaptive to maladaptive phenotype, leading to RV failure (RVF). Although RV function is well recognized as a prognostic factor of PH, no...
Autores principales: | Hautbergue, Thaïs, Antigny, Fabrice, Boët, Angèle, Haddad, François, Masson, Bastien, Lambert, Mélanie, Delaporte, Amélie, Menager, Jean-Baptiste, Savale, Laurent, Pavec, Jérôme Le, Fadel, Elie, Humbert, Marc, Junot, Christophe, Fenaille, François, Colsch, Benoit, Mercier, Olaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235667/ https://www.ncbi.nlm.nih.gov/pubmed/34205639 http://dx.doi.org/10.3390/cells10061559 |
Ejemplares similares
-
The Beneficial Effect of Suramin on Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Izikki, Mohamed, et al.
Publicado: (2013) -
Involvement of SUR2/Kir6.1 channel in the physiopathology of pulmonary arterial hypertension
por: Le Ribeuz, Hélène, et al.
Publicado: (2023) -
Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?
por: Loisel, Fanny, et al.
Publicado: (2018) -
Role of Store-Operated Ca(2+) Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial Hypertension
por: Masson, Bastien, et al.
Publicado: (2021) -
In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression
por: Le Ribeuz, Hélène, et al.
Publicado: (2020)